-
Huang Guo meets acting director of WHO’s Regulation and Prequalification Department
On Nov 2, Huang Guo, Commissioner of China's National Medical Products Administration (NMPA), met in Beijing with a delegation led by Hiiti Sillo, acting director of the Regulation and Prequalification Department of the World Health Organization (WHO), and Martin Taylor, WHO representative to China.
-
Lei Ping meets with deputy head of Russian Federal Service for Surveillance in Healthcare
On Oct 23, Lei Ping, deputy commissioner of China's National Medical Products Administration (NMPA), met with a delegation led by Dmitry Pavlyukov, deputy head of the Federal Service for Surveillance in Healthcare of the Russian Federation (Roszdravnadzor).
-
Traditional medicine regulation and industrial innovation forum held in Beijing
The Traditional Medicine Regulation and Industrial Innovation Forum, a parallel session of the World Conference on Traditional Medicine 2026, was held in Beijing on Oct 18.
- Announcement of the National Medical Products Administration, the National Health Commission, the National Administration of Traditional Chinese Medicine, and the National Disease Control and Prevention Administration on Issuing the Good Clinical Practice (No. 50, 2026)
- Good Clinical Practice for Drugs (2026 Revision): Questions and Answers
- Work Procedure for the Protection of Drug Regulatory Data
- Announcement of the National Medical Products Administration, the National Health Commission, the National Administration of Traditional Chinese Medicine, and the National Disease Control and Prevention Administration on Issuing the Good Clinical Practice (No. 50, 2026)
- Good Clinical Practice for Drugs (2026 Revision): Questions and Answers
- Work Procedure for the Protection of Drug Regulatory Data







